Open Research will be unavailable from 3am to 7am on Thursday 4th December 2025 AEDT due to scheduled maintenance.
 

Bone turnover 18 months after a single intravenous dose of zoledronic acid

Date

Authors

Borba, LuizAlencar
Da Paz Filho, Gilberto
kulak, carolina A
Seibel, Markus J.
Bilezikian, John P

Journal Title

Journal ISSN

Volume Title

Publisher

Blackwell Publishing Ltd

Abstract

Zoledronic acid inhibits bone resorption for up to 12 months. It is not known whether the duration of this antiresorptive effect extends beyond this period of time. The aim of this study was to evaluate the changes in bone turnover at 12 months (T12) and

Description

Citation

Source

International Journal of Clinical Practice

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31